Patients with chronic spontaneous urticaria experienced early symptom improvements that were sustained through 52 weeks with remibrutinib, according to a presentation at the European Academy of Allergy & Clinical Immunology Congress. The safety profile for the Bruton’s tyrosine kinase (BTK) inhibitor was favorable and consistent through 52 weeks as well, the researchers said.
RNA interference silences RAGE with no detrimental effect on lungs in patients with asthma healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Mepolizumab safety profile comparable with placebo across 32 studies, multiple indications healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO — Patients with asthma experienced significant reductions in mucus airway plugging and mucus volume with dupilumab, according to a presentation at the American Thoracic Society International Conference.These patients also saw reduced airway inflammation, further improving lung function, Mario Castro, MD, MPH, L.E. Phillips and Lenora Carr Phillips Professor at the University of
SAN DIEGO — Type 2 inflammation and asthma were significantly associated with higher risk for coronary artery disease, according to a presentation at the American Thoracic Society International Conference. Higher eosinophil counts also were significantly associated with coronary artery disease, Christa McPhee, MD, pulmonary and critical care medicine fellow, division of pulmonary, critical